News

We’re proud to support Sempre Health to advance its mission of reducing medication costs and improving member adherence for patients with chronic disease.

What makes Echo Health Ventures different from other corporate venture partners is that we invest under a dual mandate to drive both strategic impact and financial returns.

At Echo, we partner with innovative companies working to transform the health care industry and help them build relationships to deliver sustainable, impactful market solutions.

Thyme Care, the leading value-based cancer care enabler, today announced investment from Echo Health Ventures, a strategic investment platform investing on behalf of multiple Blues health plans, and CVS Health Ventures, the venture arm of CVS Health.

Main Street Health, the nation’s largest value-based healthcare organization exclusively serving rural America, announced it has raised more than $315 million, including investment from Echo Health Ventures and health plan and provider partners. 

Sempre Health, the leading solution for behavior-based healthcare pricing, today announced $20M in additional funding from three new investors, including Cencora Ventures and Echo Health Ventures. Existing investors including the Blue Venture Fund, UPMC Enterprises and Industry Ventures also participated.

Echo Health Ventures was just named to Inc.’s sixth annual Founder-Friendly Investors list, honoring the private equity, venture capital firms, and lenders with a track record of backing founder-led companies.

Echo Health Ventures was honored to host the 2024 Echo Summit earlier this month in Durham, North Carolina.

The annual list features the 100 most influential people in corporate venture capital.